Memorial Hermann–Texas Medical Center is a nationally ranked hospital at the Texas Medical Center. It is the first hospital founded in the Texas Medical Center in Houston, Texas.

During the past decade, Memorial Hermann Texas Medical Center conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 49 clinical trials were completed, i.e. on average, 68.1% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 29 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Hermann Texas Medical Center" #1 sponsor was "The University of Texas Health Science Center, Houston" with 31 trials, followed by "National Cancer Institute (NCI)" with 13 trials sponsored, "Gynecologic Oncology Group" with 7 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "GOG Foundation" with 5 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Hermann Texas Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "Medical University of South Carolina" with 10 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "University of Cincinnati" with 6 trials as a collaborator. Other collaborators include 101 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Hermann Texas Medical Center" are "Ischemic Stroke" (5 trials), "Cervical Adenocarcinoma" (4 trials), "Cervical Adenosquamous Carcinoma" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Recurrent Squamous Cell Lung Carcinoma" (4 trials). Many other conditions were trialed in "Memorial Hermann Texas Medical Center" in a lesser frequency.

Most popular intervention types in "Memorial Hermann Texas Medical Center" are "Drug" (51 trials), "Other" (38 trials), "Device" (28 trials), "Procedure" (22 trials) and "Biological" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (16 trials), "Questionnaire Administration" (11 trials), "Placebo" (10 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Hermann Texas Medical Center" are 87 trials for "All" genders and 26 trials for "Female" genders.

Currently, there are 49 active trials in "Memorial Hermann Texas Medical Center". 1 are not yet recruiting, 20 are recruiting, 26 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 37 completed trials in Memorial Hermann Texas Medical Center, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Hermann Texas Medical Center, 5 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 33 trials that are defined as “Not Applicable".

Memorial Hermann Texas Medical Center has several departments that took part in Clinical trials: "Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center" - 7 trials, "Laila A Hassan, MD, PA" - 4 trials, "Memorial Hermann Katy Rehab" - 3 trials, "Ertan Digestive Disease Center" - 2 trials, "Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hospital Southeast" - 2 trials, "Asif Cochinwala, MD, PA" - 2 trials, "Amir A Hassan, MD, PA" - 2 trials